Detalles de la búsqueda
1.
Application of the Hollow-Fiber Infection Model to Personalized Precision Dosing of Isoniazid in a Clinical Setting.
J Korean Med Sci;
39(13): e104, 2024 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38599596
2.
Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure.
Int J Antimicrob Agents;
63(2): 107034, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37977236
3.
Alterations of lipid-related genes during anti-tuberculosis treatment: insights into host immune responses and potential transcriptional biomarkers.
Front Immunol;
14: 1210372, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38022579
4.
Risk adjustment model for tuberculosis compared to non-tuberculosis mycobacterium or latent tuberculosis infection: Center for Personalized Precision Medicine of Tuberculosis (cPMTb) cohort database.
BMC Pulm Med;
23(1): 471, 2023 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38001469
5.
Evaluation of pharmacokinetic drug-drug interaction between tegoprazan and clarithromycin in healthy subjects.
Transl Clin Pharmacol;
31(2): 114-123, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37440779
6.
Pathway-level multi-omics analysis of the molecular mechanisms underlying the toxicity of long-term tacrolimus exposure.
Toxicol Appl Pharmacol;
473: 116597, 2023 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37321324
7.
Development of a population pharmacokinetic model of pyrazinamide to guide personalized therapy: impacts of geriatric and diabetes mellitus on clearance.
Front Pharmacol;
14: 1116226, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37305528
8.
Recommendation of pharmacokinetics/pharmacodynamics target of ethambutol to suppress tuberculosis resistance: A population pharmacokinetics study on a large prospective cohort.
Int J Antimicrob Agents;
62(2): 106840, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37160240
9.
Multimodal plasma metabolomics and lipidomics in elucidating metabolic perturbations in tuberculosis patients with concurrent type 2 diabetes.
Biochimie;
211: 153-163, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37062470
10.
CYP2C19 Contributes to THP-1-Cell-Derived M2 Macrophage Polarization by Producing 11,12- and 14,15-Epoxyeicosatrienoic Acid, Agonists of the PPARγ Receptor.
Pharmaceuticals (Basel);
16(4)2023 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37111350
11.
Systems-level multi-omics characterization provides novel molecular insights into indomethacin toxicity.
Chem Biol Interact;
375: 110430, 2023 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36868495
12.
Comprehensive lipid profiles investigation reveals host metabolic and immune alterations during anti-tuberculosis treatment: Implications for therapeutic monitoring.
Biomed Pharmacother;
158: 114187, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36916440
13.
Advancing personalized medicine for tuberculosis through the application of immune profiling.
Front Cell Infect Microbiol;
13: 1108155, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36844400
14.
Development of population pharmacokinetics model and Bayesian estimation of rifampicin exposure in Indonesian patients with tuberculosis.
Tuberculosis (Edinb);
139: 102325, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36841141
15.
Population Pharmacokinetics of Levofloxacin and Moxifloxacin, and the Probability of Target Attainment in Ethiopian Patients with Multidrug-Resistant Tuberculosis.
Infect Drug Resist;
15: 6839-6852, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36465811
16.
Quantitative Analysis of Isoniazid and Its Four Primary Metabolites in Plasma of Tuberculosis Patients Using LC-MS/MS.
Molecules;
27(23)2022 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36500699
17.
Characterization of Clofazimine Metabolism in Human Liver Microsomal Incubation In Vitro.
Antimicrob Agents Chemother;
66(10): e0056522, 2022 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36190267
18.
Comprehensive lipid and lipid-related gene investigations of host immune responses to characterize metabolism-centric biomarkers for pulmonary tuberculosis.
Sci Rep;
12(1): 13395, 2022 08 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35927287
19.
Genome-wide gene expression analysis reveals molecular insights into the drug-induced toxicity of nephrotoxic agents.
Life Sci;
306: 120801, 2022 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35850247
20.
Semi-Automated Therapeutic Drug Monitoring as a Pillar toward Personalized Medicine for Tuberculosis Management.
Pharmaceutics;
14(5)2022 May 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35631576